Info

ApoCell is an innovative molecular diagnostics company specializing in biomarker assay development, discovery and validation for clinical applications. Scientists at ApoCell have developed innovative technologies to quantitate biomarkers for oncology drug development, and for predicting, diagnosing, and monitoring therapeutic response. ApoCell's technology offers the potential to accelerate biotechnology and pharmaceutical drug development, decrease healthcare costs and significantly improve the quality of life for patients with life-threatening diseases. ApoCell has integrated multiple platform technologies to perform high complexity biomarker analysis of proteins, RNA and DNA. ApoCell scientists have developed a comprehensive technological approach to analyze exploratory biomarkers in various specimen types to provide quantitative information about the biological effects of drugs. Biomarkers identified through this methodical process have been shown to correlate with clinical outcome on FDA approved drugs. ApoCell has discovered several biomarkers that are undergoing validation for clinical diagnostic applications.